| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 01/17/2007 | EP1392309B1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 01/17/2007 | EP1345900B1 Guanidine and amidine derivatives as factor xa inhibitors |
| 01/17/2007 | EP1224314B1 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna |
| 01/17/2007 | EP1180518B1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 01/17/2007 | EP1179539B1 Protein having hemolytic activity and gene encoding the protein |
| 01/17/2007 | CN1898197A Novel compounds |
| 01/17/2007 | CN1897963A Use of cyclic anabaenopeptin-type peptides for the treatment of a condition wherein inhibition of carboxypeptidase u is beneficial, novel anabaenopeptin derivatives and intermediates thereof |
| 01/17/2007 | CN1897952A Neutrophilia inhibitor |
| 01/17/2007 | CN1896232A Ginkgo endogenous fusanin plasminogen, its production and use |
| 01/17/2007 | CN1896224A Fermented cordycepin micrograin, its production and use |
| 01/17/2007 | CN1896108A Preparation of specific anticoagulation matter and its use |
| 01/17/2007 | CN1896103A N-terminally monopegylated polypeptides and process for their preparation |
| 01/17/2007 | CN1896088A C－芳基葡糖苷sglt2抑制剂 C- aryl glucoside sglt2 inhibitors |
| 01/17/2007 | CN1895558A Oral medicine for treating cerebral blood-supply deficiency giddiness and cava infarction and hyperthrombinemia |
| 01/17/2007 | CN1895457A Preparation of Japanese beauty-berry and its inspection |
| 01/17/2007 | CN1895450A Blood-tonifying beverage |
| 01/17/2007 | CN1895405A Garden-Burnet-Sheng-Bai capsules and preparation thereof |
| 01/17/2007 | CN1895392A Chinese-medicinal preparation for treating cardiovascular and cerebrovascular disease and its making method |
| 01/17/2007 | CN1895378A Quality control for aqueous donkey-hide gelatin and Chinese angelica preparation |
| 01/17/2007 | CN1895364A Decumbent corydalis Rhizome medicinal composition for treating cerebral thrombosis sequela and rheumatic arthritis |
| 01/17/2007 | CN1895352A Preparation of Danshen root microemulsion |
| 01/17/2007 | CN1895346A Chinese-medicinal preparation for treating cardivascular and cerebrovascular diseases and its making method |
| 01/17/2007 | CN1895304A Drug liquid for treating digestive ulcerative bleeding |
| 01/17/2007 | CN1895298A Medicinal preparation for treating and preventing coronary heart disease and thromboembolia disease and its preparation |
| 01/17/2007 | CN1895276A Injection medicine for treating platelet abatement |
| 01/17/2007 | CN1895264A Medicinal use of quercetin-3-0-beta-D-glucancoside |
| 01/17/2007 | CN1895260A Sucrose-ferri aseptic powdery injection and its preparation |
| 01/17/2007 | CN1895243A Danshen-root ketone IIA oral-cavity disintegrating tablets |
| 01/17/2007 | CN1895226A Matrine elaioplast drop ball and its preparation |
| 01/17/2007 | CN1295251C Glycosaminoglycans derived from K5 polysaccharide having high antithrombin activity and process for their preparation |
| 01/17/2007 | CN1295227C Barbituric acid derivs with antimetastatic and antitumor activity |
| 01/17/2007 | CN1295221C Substituted heterocyclic compounds |
| 01/17/2007 | CN1295213C Fluorinated cycloalkyl-derivatized benzoylguanidines and their uses as medicament |
| 01/17/2007 | CN1294986C Process for producing ampeptide element |
| 01/17/2007 | CN1294901C Embolism eliminatinging drop pills with qi invigorating, blood flow promoting and collateral dredging function |
| 01/16/2007 | US7163951 N-biarylmethyl aminocycloalkanecarboxamide derivatives |
| 01/16/2007 | US7163938 Substituted carboxamides |
| 01/16/2007 | US7163824 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 01/16/2007 | US7163808 Method for selectively delivering agent to arterial smooth muscle cells in mammal comprising administering agent and substance which selectively binds arterial smooth muscle cell-specific surface molecule selected from ephrin family |
| 01/16/2007 | US7163704 Injection made from Ixeris Sonchifolia Hance for treatment of cardio-cerebral vascular diseases and fundus diseases and method of producing thereof |
| 01/16/2007 | CA2168963C Drug for prevention and therapy of diseases caused by fibrinoid formation or thrombus formation in the lung and model animals of the diseases |
| 01/16/2007 | CA2103996C Dimer of molecular variant of apolipoprotein and processes for the production thereof |
| 01/12/2007 | CA2550493A1 Packaging of ferric pyrophosphate for dialysis |
| 01/11/2007 | WO2007004966A1 USE OF LACTOBACILLUS FOR INCREASING THE ABSORPTION OF A METAL CHOSEN FROM Fe, Zn, Ca AND IONS THEREOF |
| 01/11/2007 | WO2007004523A1 Pharmaceutical composition and beverage composition comprising l-arginine |
| 01/11/2007 | WO2007004390A1 Cachexia improving preparation and cachexia improving food |
| 01/11/2007 | WO2007004038A1 Aminothiazole derivatives as agonists of the thrombopoietin receptor |
| 01/11/2007 | WO2007003010A1 Anticoagulation agent and uses thereof |
| 01/11/2007 | WO2006032342A3 Carbonyl compound-containing drug and the use thereof |
| 01/11/2007 | US20070010581 Use of 2,5-dihydroxybenzenesulfonic compounds for the treatment of disorders based on an impairment of no production and/or of regulation of edhf function |
| 01/11/2007 | US20070010528 excellent efficacy, oral absorbability, sustained effect, fewer side effects; for thrombosis; anticoagulants; N-(4-((4-( 3-((6-chloro-2-naphthyl)sulfonyl)propanoyl)-1-piperazinyl)methyl)-3-methyl-1,3-thiazol-2(3H)-ylidene)-N-methylamine |
| 01/11/2007 | US20070010521 Condensed polycyclic compounds |
| 01/11/2007 | US20070010515 [1,2,4] Triazolo [1,5, a] pyrimidin-2-ylurea derivative and use thereof |
| 01/11/2007 | US20070010499 Medicinal compositions containing aspirin |
| 01/11/2007 | US20070010490 T-type calcium channel blockers |
| 01/11/2007 | US20070010473 Nucleic acid ligands to integrins |
| 01/11/2007 | US20070010472 Oligonucleotide compositions and their use to induce differentiation of cells |
| 01/11/2007 | US20070010457 Caspase inhibitors and uses thereof |
| 01/11/2007 | US20070010030 Complement C3 precursor biopolymer markers indicative of insulin resistance |
| 01/11/2007 | US20070009951 Gene expression vaccine |
| 01/11/2007 | US20070009538 Expression and export of angiogenesis inhibitors as immunofusins |
| 01/11/2007 | US20070009522 administering to an Rh-negative individual in need of an anti-Rh(D) monoclonal antibody, wherein monoclonal antibody exhibits a Fc gamma RTIII-type ADCC ( antibody-dependent cell-mediated cytotoxicity (ADCC) assays) level greater than 80% relative to a reference polyclonal anti-Rh(D) human antibody |
| 01/11/2007 | US20070009519 Immunoregulatory Antibodies and Uses Thereof |
| 01/11/2007 | CA2614017A1 Steroidal glycoside compounds as core 2 glcnac- t inhibitors |
| 01/11/2007 | CA2613691A1 Anticoagulation agent and uses thereof |
| 01/10/2007 | EP1741713A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/10/2007 | EP1741453A2 Collagen substrate, method of manufacturing the same, and method of using the same |
| 01/10/2007 | EP1740594A1 Clopidogrel salt and polymorphic forms thereof |
| 01/10/2007 | EP1740569A1 Imidazole derivatives used as tafia inhibitors |
| 01/10/2007 | EP1740538A2 Bicyclic heterocycles useful as serine protease inhibitors |
| 01/10/2007 | EP1416885B1 Devices for delivery of therapeutic agents with variable release profile |
| 01/10/2007 | EP1414440B1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 01/10/2007 | EP1232180B1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
| 01/10/2007 | CN1894280A Glycosylation-deficient hepatocyte growth factor |
| 01/10/2007 | CN1894244A Aryl ether substituted imidazoquinolines |
| 01/10/2007 | CN1894238A Diamine derivatives |
| 01/10/2007 | CN1894214A New 5,6-dihydropyrin-2-one compounds useful as inhibitors of thrombin |
| 01/10/2007 | CN1894210A Prolinylarylacetamides |
| 01/10/2007 | CN1894195A Ether compounds and compositions for cholesterol management and related uses |
| 01/10/2007 | CN1893960A A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma |
| 01/10/2007 | CN1893936A ((((1h-indol-3yl) methylidene)amino)oxy)acetic acid derivatives and related compounds as pai-1 inhibitors for the treatment of inpairement of the fibrinolytic system and of thrombosis |
| 01/10/2007 | CN1891280A Nano Mailuoning injection preparation and its preparing method |
| 01/10/2007 | CN1891268A Chinese medicine preparation for treating cardio-cerebrovascular disease, and its preparing method |
| 01/10/2007 | CN1891255A Blood total flavone extract, and its preparing method and use |
| 01/10/2007 | CN1891251A Method for preparing Naoan capsule water-soluble substance |
| 01/10/2007 | CN1891249A Chinese medicine preparation for treating cardio-cerebrovascular disease and its preparing method |
| 01/10/2007 | CN1891240A Chinese medicine composition containing multi glossy ganoderma active constituents and its preparing method |
| 01/10/2007 | CN1891234A Leech polypeptide lyophilized powder injection preparation and its preparing method |
| 01/10/2007 | CN1294117C Amidino compound and salts thereof useful as nitric oxide synahase inhibitors |
| 01/10/2007 | CN1293896C Medication for treating primary thrombocytopenic purpura and preparation method thereof |
| 01/10/2007 | CN1293868C Application of alpha cyclo-alanine in the process for preparing medicine to treat cerebrovascular and cardiovascular disease |
| 01/09/2007 | US7160900 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/09/2007 | US7160892 Pyrimidone compounds and pharmaceutical compositions containing the same |
| 01/09/2007 | US7160878 Substituted heterocyclic amides |
| 01/09/2007 | US7160870 Thrombopoietin mimetics |
| 01/09/2007 | CA2227533C Improved therapeutic agents |
| 01/04/2007 | WO2007002637A1 N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 01/04/2007 | WO2007002584A1 Linear urea mimics antagonists of p2y1 receptor useful in the treatment of thrombotic conditions |
| 01/04/2007 | WO2006103544A3 4-piperazinylthieno [2, 3-d] pyrimidine compounds as platelet aggregation inhibitors |
| 01/04/2007 | WO2006062973A3 Use of organic compounds |